NCT07548541

Brief Summary

This randomized, double-blind, four-period crossover trial investigates the acute effects of creatine monohydrate, L-arginine, and their combined administration on anaerobic performance, jump performance, and cognitive reaction time in recreationally active adult males. Eighteen healthy male participants complete four experimental conditions in randomized order: placebo, creatine, L-arginine, and creatine plus L-arginine, with at least 72 hours between sessions. Sixty minutes after supplementation, participants perform the Stroop Color-Word Test, countermovement jump test, and Running-Based Anaerobic Sprint Test. Primary outcomes include peak power, average power, countermovement jump height, and incongruent Stroop reaction time. The study aims to determine whether acute co-supplementation produces greater ergogenic and cognitive benefits than either supplement alone or placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 16, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 14, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

April 14, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

CreatineL-ArginineDietary SupplementationCountermovement JumpRunning-Based Anaerobic Sprint TestStroop TestReaction TimeRecreational AthletesCrossover Trial

Outcome Measures

Primary Outcomes (4)

  • RAST Average Power

    Average power during the Running-Based Anaerobic Sprint Test following acute supplementation.

    60 minutes after supplementation, during the testing session

  • RAST Peak Power

    Peak power during the Running-Based Anaerobic Sprint Test following acute supplementation.

    60 minutes after supplementation, during the testing session

  • Countermovement Jump Height

    Best countermovement jump height measured using the Optojump system following acute supplementation.

    60 minutes after supplementation, during the testing session

  • Stroop Incongruent Median Reaction Time

    Median reaction time in the incongruent condition of the computerized Stroop Color-Word Test following acute supplementation.

    60 minutes after supplementation, during the testing session

Secondary Outcomes (2)

  • RAST Minimum Power

    60 minutes after supplementation, during the testing session

  • RAST Fatigue Index

    60 minutes after supplementation, during the testing session

Study Arms (4)

Placebo

PLACEBO COMPARATOR

Participants received 6 g sucrose dissolved in 250 mL of water as the placebo condition.

Other: Placebo

Creatine

EXPERIMENTAL

Participants received a single acute dose of creatine monohydrate at 0.3 g/kg dissolved in 250 mL of water.

Dietary Supplement: Creatine Monohydrate

L-Arginine

EXPERIMENTAL

Participants received a single acute dose of 6 g L-arginine dissolved in 250 mL of water.

Dietary Supplement: L-Arginine

Creatine + L-Arginine

EXPERIMENTAL

Participants received combined acute supplementation with creatine monohydrate at 0.3 g/kg plus 6 g L-arginine in 250 mL of water.

Dietary Supplement: Creatine MonohydrateDietary Supplement: L-Arginine

Interventions

Creatine MonohydrateDIETARY_SUPPLEMENT

Acute oral creatine monohydrate supplementation at 0.3 g/kg body mass.

CreatineCreatine + L-Arginine
L-ArginineDIETARY_SUPPLEMENT

Acute oral L-arginine supplementation at a dose of 6 g.

Creatine + L-ArginineL-Arginine
PlaceboOTHER

Placebo beverage containing 6 g sucrose dissolved in 250 mL of water.

Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male recreational athletes aged 18 years or older
  • At least 2 years of regular participation in organized sport
  • Apparently healthy and able to complete high-intensity exercise testing

You may not qualify if:

  • Known orthopedic, neurological, cardiovascular, pulmonary, or metabolic disorders
  • Use of anabolic steroids or performance-enhancing drugs within the previous 3 months
  • Use of psychoactive or stimulant substances during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inonu University, Faculty of Sport Sciences

Malatya, Malatya, 44280, Turkey (Türkiye)

Location

Related Publications (6)

  • d'Unienville NMA, Blake HT, Coates AM, Hill AM, Nelson MJ, Buckley JD. Effect of food sources of nitrate, polyphenols, L-arginine and L-citrulline on endurance exercise performance: a systematic review and meta-analysis of randomised controlled trials. J Int Soc Sports Nutr. 2021;18:76. https://doi.org/10.1186/s12970-021-00472-y

    BACKGROUND
  • Nyawose S, Naidoo R, Naumovski N, McKune AJ. The Effects of Consuming Amino Acids L-Arginine, L-Citrulline (and Their Combination) as a Beverage or Powder, on Athletic and Physical Performance: A Systematic Review. Beverages. 2022;8:48. https://doi.org/10.3390/beverages8030048

    BACKGROUND
  • Meixner B, Stegmaier J, Renner P, Koehler K, Yang W-H, Sperlich B. Supplementation of Creatine Monohydrate Improves Sprint Performance but Has no Effect on Glycolytic Contribution: A Nonrandomized, Placebo-Controlled Crossover Trial in Trained Cyclists. Curr Dev Nutr. 2025;9:104561. https://doi.org/10.1016/j.cdnut.2025.104561

    BACKGROUND
  • Vargas-Molina S, García-Sillero M, Kreider RB, Salinas E, Petro JL, Benítez-Porres J, et al. A randomized open-labeled study to examine the effects of creatine monohydrate and combined training on jump and scoring performance in young basketball players. J Int Soc Sports Nutr. 2022;19:529-42. https://doi.org/10.1080/15502783.2022.2108683

    BACKGROUND
  • Fernández-Landa J, Santibañez-Gutierrez A, Todorovic N, Stajer V, Ostojic SM. Effects of Creatine Monohydrate on Endurance Performance in a Trained Population: A Systematic Review and Meta-analysis. Sports Medicine. 2023;53:1017-27. https://doi.org/10.1007/s40279-023-01823-2

    BACKGROUND
  • Kerksick CM, Wilborn CD, Roberts MD, Smith-Ryan A, Kleiner SM, Jäger R, et al. ISSN exercise & sports nutrition review update: research & recommendations. J Int Soc Sports Nutr. 2018;15. https://doi.org/10.1186/s12970-018-0242-y

    BACKGROUND

MeSH Terms

Interventions

CreatineArginine

Intervention Hierarchy (Ancestors)

GuanidinesAmidinesOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, BasicAmino Acids, DiaminoAmino Acids, Essential

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
An independent researcher prepared coded supplement beverages, and both participants and outcome assessors were blinded to treatment allocation. All drinks were matched for color, flavor, and appearance.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Participants complete four experimental conditions in randomized counterbalanced order: placebo, creatine, L-arginine, and creatine plus L-arginine. Sessions are separated by at least 72 hours in a four-period crossover design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Inonu University

Study Record Dates

First Submitted

April 14, 2026

First Posted

April 23, 2026

Study Start

April 1, 2025

Primary Completion

May 15, 2025

Study Completion

May 16, 2025

Last Updated

April 23, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations